results from phiii solo1 trial in brcam ovarian cancer
Published 5 years ago • 161 plays • Length 7:38Download video MP4
Download video MP3
Similar videos
-
10:34
solo1: maintenance olaparib in advanced brca ovarian cancer
-
3:24
solo-1: olaparib or placebo for patients with newly diagnosed brca-mutated advanced ovarian cancer
-
3:58
solo-1: practice changing data on olaparib for ovarian cancer
-
25:59
final overall survival results from the phase 3 solo2 trial for ovarian cancer
-
3:42
comment on solo1 trial
-
7:28
comment on solo1 for advanced ovarian cancer
-
1:13
final os results from paola-1 evaluating 1l maintenance olaparib plus bevacizumab
-
3:23
niraparib significantly improves outcomes for ovarian cancer patients
-
1:57
7-year os from solo1: sustained benefit with maintenance olaparib
-
7:39
ovarian news from esmo 2018: solo-1 results for olaparib
-
3:38
solo-1: practice changing results for advanced ovarian cancer
-
3:56
solo1 trial of maintenance olaparib in advanced ovarian cancer | susana banerjee
-
8:07
highly anticipated data from the solo-1 trial
-
5:48
solo1: 7-year follow-up highlights the value of maintenance olaparib
-
4:14
olaparib continues to show positive results in advanced ovarian cancer - 7 year data
-
1:11
solo3 highlights toxicities with olaparib in ovarian cancer
-
9:31
ariel3: rucaparib as maintenance therapy in recurrent ovarian cancer patients
-
4:44
expert report on survival data from pivotal trials with parp inhibitors for brca-mut. ovarian cancer
-
2:23
dr. poveda on the results of the solo2 trial in ovarian cancer